Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P42345 (
mTOR
)
26,049
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
regulator of G protein signaling 10
(
RGS10
) protein is a GTPase activating protein that accelerates the hydrolysis of GTP and therefore canonically inactivates G proteins, ultimately terminating signaling. Rheb is a small GTPase protein that shuttles between its GDP- and GTP-bound forms to activate
mTOR
. Since
RGS10
suppression augments ovarian cancer cell viability, we sought to elucidate the molecular mechanism. Following
RGS10
suppression in serum-free conditions, phosphorylation of
mTOR
, the eukaryotic translation initiation factor 4E binding protein 1 (4E-BP1), p70S6K and S6 Ribosomal Protein appear. Furthermore, suppressing
RGS10
increases activated Rheb, suggesting
RGS10
antagonizes
mTOR
signaling via the small G-protein. The effects of
RGS10
suppression are enhanced after stimulating cells with the growth factor, lysophosphatidic acid, and reduced with
mTOR
inhibitors, temsirolimus and INK-128. Suppression of
RGS10
leads to an increase in cell proliferation, even in the presence of etoposide. In summary, the
RGS10
suppression increases Rheb-GTP and
mTOR
signaling in ovarian cancer cells. Our results suggest that
RGS10
could serve in a novel, and previously unknown, role by accelerating the hydrolysis of GTP from Rheb in ovarian cancer cells.
...
PMID:Suppression of the GTPase-activating protein RGS10 increases Rheb-GTP and mTOR signaling in ovarian cancer cells. 2631